Is pci pharma services for sale? PCI Pharma Services explores $1 billion sale: sources. (Reuters) - PCI Pharma Services, a U.S. provider of outsourced packaging and clinical trial supply services to the pharmaceutical industry, is exploring a sale that could value it at around $1 billion, including debt, according to people familiar with the matter.Who is pennpenn pharma? Penn Pharma, a PCI company, has over 35 years of experience in providing integrated drug development, clinical trial supply, manufacturing and packaging services to the international healthcare industry.Who is pci international? Based in Philadelphia, PCI provides drug development, manufacturing, clinical trial supplies and commercial packaging services to some of the world’s largest global pharmaceutical manufacturers. It operates facilities across North America and Europe.What services do pennpenn pharmacy outpatient pharmacies offer? Penn Medicine outpatient pharmacies offer a variety of services for patients and employees. Some locations also offer personalized pharmacy services that include private, 30-minute medication management consultations, demonstrations for how to take prescribed medicines, medication deliveries for patients with chronic illnesses, and more.
Pharmaceutical Packaging Design and Development Services. Standard & Specialty Dosage Forms. Pharmaceutical Product Launch and Speed-to-Market. Patient Compliance and Adherence. Commercial Packaging of Biologically-Derived Products. Packaging and Analytical Laboratory Services. Packaging QP Services.
Company Description: Because big pharmaceutical companies can't do all of their own research and manufacturing, PCI Pharma Services (formerly Penn Pharmaceutical Services) is ready to help out. PCI Pharma offers a variety of products and services, including clinical trial supplies; formulation and analytical development; chemistry, limited batch manufacturing, and controls ...